KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Short-term Investments (2020 - 2025)

Oscar Health's Short-term Investments history spans 6 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Short-term Investments rose 94.8% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 94.8%, while the annual FY2025 figure was $1.2 billion, 94.8% up from the prior year.
  • Short-term Investments reached $1.2 billion in Q4 2025 per OSCR's latest filing, up from $887.6 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.4 billion in Q4 2022 to a low of $363.6 million in Q2 2024.
  • Average Short-term Investments over 5 years is $811.4 million, with a median of $734.9 million recorded in 2022.
  • Peak YoY movement for Short-term Investments: plummeted 71.04% in 2024, then soared 157.98% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $587.1 million in 2021, then soared by 138.0% to $1.4 billion in 2022, then crashed by 50.63% to $689.8 million in 2023, then fell by 9.48% to $624.5 million in 2024, then surged by 94.8% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Short-term Investments are $1.2 billion (Q4 2025), $887.6 million (Q3 2025), and $938.1 million (Q2 2025).